STOCK TITAN

Cognex Corp SEC Filings

CGNX NASDAQ

Cognex Corporation filings document regulatory disclosures for an operating company focused on industrial machine vision products and automation technology. Its Form 8-K reports cover furnished operating results, quarterly cash dividends, share repurchase authorization, board and officer matters, annual meeting voting results, and changes in the company’s independent registered public accounting firm.

Proxy materials describe director elections, governance matters, executive compensation, shareholder voting procedures, and board committee oversight. The filing record also includes exhibit-based disclosures tied to financial-results releases and capital-return actions involving Cognex common stock.

Rhea-AI Summary

CGNX: A Form 144 disclosure reports proposed and completed sales of Common Stock by holders, including a proposed sale tied to an option and completed sales by Robert J. Willett. The excerpt lists a proposed transaction dated 05/06/2026 (option granted 02/20/2024) and completed sales on 02/12/2026 and 02/13/2026.

The completed transactions show 177,052 shares sold on 02/12/2026 for $10,300,974.15 and 2,148 shares sold on 02/13/2026 for $127,808.48. Shares outstanding are listed as 165,707,920 as of 05/06/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.88%
Tags
other
-
Rhea-AI Summary

COGNEX CORP executive Mark Fennell, Chief Legal Officer & Secretary, has filed an initial ownership report showing his equity position in the company. He directly holds 4,863 shares of common stock, along with several blocks of restricted stock units and non-qualified stock options tied to Cognex common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

COGNEX CORP vice president Darren Marc Long filed a Form 3 showing his current equity stake in the company. He directly holds 5,569 shares of common stock, plus multiple restricted stock units and non-qualified stock options over Cognex common stock with various exercise prices and expiration dates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Cognex Corp vice president Michael Bowdoin filed an initial ownership report showing he directly holds 11,139 shares of common stock. He also reports multiple restricted stock units that can convert into common shares, and several non-qualified stock options with exercise prices ranging from $33.04 to $90.50 per share and expirations extending through 2036.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cognex Corporation reported governance updates from its 2026 annual meeting and a change in officer status. The board determined that Joerg Kuechen will no longer be treated as an “executive officer” under Exchange Act rules, and he will remain with the company as Head of Mergers and Acquisitions.

At the meeting, shareholders representing 153,890,280 of 167,013,856 shares outstanding as of the record date approved all proposals recommended by the board. Three directors—Matthew Moschner, Angelos Papadimitriou and Christopher Donato—were elected to terms ending in 2029. Shareholders also approved an amendment to the 2023 Stock Option and Incentive Plan, ratified KPMG LLP as independent registered public accounting firm for fiscal 2026, and gave advisory approval to executive compensation as described in the proxy statement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Cognex Corp reported that Vanguard Capital Management disclosed beneficial ownership of 8,705,689 shares of Common Stock, representing 5.21% of the class. The filing states Vanguard has sole dispositive power over 8,705,689 shares and sole voting power for 1,275,533 shares. The filing is a Schedule 13G disclosure signed on 04/29/2026 and describes holdings held on behalf of Vanguard-managed funds and accounts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Cognex Corp reports a Schedule 13G showing Vanguard Portfolio Management beneficially owns 10,390,950 shares of Common Stock. The filing states this equals 6.22% of the class and attributes dispositive power to Vanguard Portfolio Management LLC and affiliated business divisions. The filing lists 20,303 shares of sole voting power and affirms holdings are managed on behalf of multiple clients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

The Vanguard Group files an amendment stating it holds 0 shares (0%) of Cognex Corp common stock. The filing notes an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries to report holdings separately. The statement is signed by Ashley Grim, Head of Global Fund Administration on 03/26/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

COGNEX CORP director Christopher Donato filed an initial Form 3, which records his status as a reporting insider of the company. The filing reports no purchases, sales, or other transactions in Cognex stock, serving only as a baseline disclosure of his insider position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

COGNEX CORP director Sami Atiya filed an initial insider ownership report on the company’s stock. The filing is a Form 3, which establishes Atiya’s status as a director and provides a baseline disclosure of insider holdings. It reports no purchases, sales, exercises, gifts, or other transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Cognex (CGNX) SEC filings are available on StockTitan?

StockTitan tracks 76 SEC filings for Cognex (CGNX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Cognex (CGNX)?

The most recent SEC filing for Cognex (CGNX) was filed on May 6, 2026.